BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 7, 2004
View Archived Issues
Incara receives approval for phase II SBIR grant for catalytic antioxidant work
Read More
Enrollment concludes in TAXUS V study
Read More
Millennium and NCI to study link between ACE2 and SARS
Read More
Long-term effects of Diamyd in patients with autoimmune diabetes
Read More
Decitabine delays progression to AML in patients with myelodysplastic syndromes
Read More
TLK-286 increases the efficacy of antitumor drugs in vitro
Read More
Antitumor effects of the chemosensitizer phenoxodiol in prostate and ovarian cancer
Read More
Dual PPARalpha/gamma agonist effective against metabolic syndrome in vivo
Read More
Integrin antagonists show good potency, selectivity and bioavailability
Read More
Novel integrin antagonist may be effective for post-PCI restenosis
Read More
New DPP-IV inhibitors prepared and tested by Eisai researchers
Read More
Axxima claims new inhibitors of herpes virus UL97 kinase
Read More
Novel protein kinase inhibitors in early development at Vertex
Read More
Two series of Itk inhibitors recently claimed by AstraZeneca
Read More
AstraZeneca scientists develop new alpha7 nAchR agonists
Read More
Inhibitors of CDK2 and other kinases emerge from Cyclacel R&D
Read More
CX-3543, a novel c-Myc oncogene inhibitor, shows efficacy in vivo
Read More
RS-5444, a PPARgamma agonist, shows high affinity against thyroid tumor growth
Read More
Promising tubulin-binding compound with antimitotic activity
Read More
DynPort develops tularemia vaccine under NIAID award
Read More
Germany approves ezetimibe/simvastatin for hypercholesterolemia
Read More
Primovist receives approval in Sweden
Read More
Ardana acquires global rights to Teverelix
Read More
Improvement in survival indicated in phase IIb trial of L-BLP-25
Read More
Clofarabine NDA submission completed
Read More
First preclinical data on MEK inhibitor ARRY-142886 presented
Read More
ZymoGenetics cleared to commence phase I study of IL-21
Read More
Broad activity of cell cycle inhibitor SNS-595 in cancer models
Read More
Enrollment commences in MEND-CABG trial of MC-1
Read More
Cardizem approved for chronic stable angina
Read More
QR-336 protects mice in a lethal-dose radiation study
Read More
DSMB recommends dosing of final patients in VRX-496 phase I trial
Read More
AP-23464 effective against imatinib-resistant leukemia cells
Read More
Aventis Supervisory Board recommends negotiation of tie-up with Novartis
Read More